STOCK TITAN

Select Medical Holdings Corporation Completes Spin-Off of Concentra

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

Select Medical Holdings (NYSE: SEM) has completed the distribution of 104,093,503 shares (81.7%) of Concentra (NYSE: CON) common stock to its stockholders. The distribution occurred on November 25, 2024, with stockholders receiving 0.806971 Concentra shares for each Select Medical share held as of the November 18, 2024 record date. Following this spin-off, Select Medical no longer holds any Concentra shares. J.P. Morgan and Goldman Sachs served as financial advisors for the distribution.

Select Medical Holdings (NYSE: SEM) ha completato la distribuzione di 104.093.503 azioni (81,7%) di Concentra (NYSE: CON) ai suoi azionisti. La distribuzione è avvenuta il 25 novembre 2024, con gli azionisti che hanno ricevuto 0,806971 azioni Concentra per ogni azione di Select Medical detenuta alla data di registrazione del 18 novembre 2024. Dopo questa scissione, Select Medical non detiene più azioni Concentra. J.P. Morgan e Goldman Sachs hanno fatto da consulenti finanziari per la distribuzione.

Select Medical Holdings (NYSE: SEM) ha completado la distribución de 104.093.503 acciones (81.7%) de Concentra (NYSE: CON) a sus accionistas. La distribución ocurrió el 25 de noviembre de 2024, con los accionistas recibiendo 0.806971 acciones de Concentra por cada acción de Select Medical que poseían al 18 de noviembre de 2024, fecha de registro. Tras esta escisión, Select Medical ya no posee acciones de Concentra. J.P. Morgan y Goldman Sachs actuaron como asesores financieros para la distribución.

셀렉트 메디컬 홀딩스 (NYSE: SEM)는 콘센트라 (NYSE: CON) 보통주 104,093,503주 (81.7%)를 주주에게 배포했습니다. 배포는 2024년 11월 25일에 이루어졌으며, 주주들은 2024년 11월 18일의 기준일 기준으로 보유한 셀렉트 메디컬 주식 1주당 0.806971 콘센트라 주식을 받았습니다. 이 스핀오프 이후 셀렉트 메디컬은 더 이상 콘센트라 주식을 보유하고 있지 않습니다. J.P. 모건과 골드만삭스는 배포를 위한 재정 고문 역할을 했습니다.

Select Medical Holdings (NYSE: SEM) a complété la distribution de 104.093.503 actions (81,7%) de Concentra (NYSE: CON) à ses actionnaires. La distribution a eu lieu le 25 novembre 2024, les actionnaires recevant 0,806971 actions de Concentra pour chaque action de Select Medical détenue à la date de référence du 18 novembre 2024. Après cette scission, Select Medical ne détient plus d'actions de Concentra. J.P. Morgan et Goldman Sachs ont agi en tant que conseillers financiers pour la distribution.

Select Medical Holdings (NYSE: SEM) hat die Verteilung von 104.093.503 Aktien (81,7%) von Concentra (NYSE: CON) an seine Aktionäre abgeschlossen. Die Verteilung fand am 25. November 2024 statt, wobei die Aktionäre 0,806971 Concentra-Aktien für jede am 18. November 2024 gehaltene Select Medical-Aktie erhielten. Nach dieser Abspaltung hält Select Medical keine Concentra-Aktien mehr. J.P. Morgan und Goldman Sachs fungierten als Finanzberater für die Verteilung.

Positive
  • Complete divestiture of Concentra business segment allows for clearer business focus
  • Distribution of shares directly to stockholders maintains shareholder value
Negative
  • Loss of revenue stream from Concentra segment
  • Reduction in business diversification

Insights

The spin-off of Concentra represents a significant strategic move for Select Medical, effectively separating its occupational health business from its core hospital and rehabilitation operations. Select Medical stockholders received 0.806971 Concentra shares for each SEM share, distributing approximately 81.7% of Concentra's ownership.

This transaction allows both companies to operate independently and focus on their respective core competencies. For Select Medical, this means streamlining operations around critical illness recovery hospitals, rehabilitation hospitals and outpatient rehabilitation clinics. The separation could potentially unlock value by allowing investors to better evaluate each business separately and enabling more focused capital allocation strategies.

The involvement of major financial advisors J.P. Morgan and Goldman Sachs suggests the complexity and significance of this corporate restructuring. Investors should monitor both companies' independent performance metrics and market valuations post-spin-off, as such transactions typically take several months to realize their full market impact.

MECHANICSBURG, Pa., Nov. 25, 2024 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") (NYSE: SEM) today announced that we have completed our previously announced distribution (the "Distribution") of 104,093,503 shares of common stock of Concentra Group Holdings Parent, Inc. ("Concentra") (NYSE: CON) owned by Select Medical Corporation ("SMC"), a wholly owned subsidiary of Select Medical, representing approximately 81.7% of the outstanding shares of Concentra's common stock. After the completion of the Distribution, Select Medical no longer owns any shares of Concentra's common stock.

The Distribution was made today to Select Medical's stockholders as of the close of business on the record date (the "Record Date") for the Distribution, November 18, 2024. The Distribution took place in the form of a pro rata common stock distribution to each of Select Medical's stockholder on the Record Date. Based on the shares of Select Medical's common stock outstanding as of the Record Date, Select Medical's stockholders received 0.806971 shares of Concentra's common stock for every share of Select Medical's common stock held as of the Record Date.

No fractional shares of Concentra's common stock were distributed. Instead, Select Medical's stockholders will receive cash in lieu of any fraction of a share of Concentra's common stock that they otherwise would have received.

On November 19, 2024, Select Medical made available an information statement to its stockholders on the Record Date, which included details on the Distribution. The information statement is posted under the Investor Relations tab on Select Medical's website at www.selectmedical.com/investor-relations/.

J.P. Morgan and Goldman Sachs acted as financial advisors to Select Medical in connection with the Distribution. Dechert LLP acted as legal advisor to Select Medical in connection with the Distribution.

About Select Medical

Select Medical is one of the largest operators of critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States based on number of facilities. Select Medical's reportable segments include the critical illness recovery hospital segment, the rehabilitation hospital segment, the outpatient rehabilitation segment, and the Concentra segment. As of September 30, 2024, Select Medical operated 106 critical illness recovery hospitals in 29 states, 34 rehabilitation hospitals in 13 states, 1,925 outpatient rehabilitation clinics in 39 states and the District of Columbia, and 549 occupational health centers in 41 states. At September 30, 2024, Select Medical had operations in 46 states and the District of Columbia. Information about Select Medical is available at www.selectmedical.com.

This press release may contain forward-looking statements based on current management expectations. Numerous factors, including those related to market conditions and those detailed from time-to-time in Select Medical's filings with the Securities and Exchange Commission, may cause results to differ materially from those anticipated in the forward-looking statements. Many of the factors that will determine Select Medical's future results are beyond the ability of Select Medical to control or predict. These statements are subject to risks and uncertainties and, therefore, actual results may differ materially. Readers should not place undue reliance on forward-looking statements, which reflect management's views only as of the date hereof. Select Medical undertakes no obligation to revise or update any forward-looking statements, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.

Investor inquiries:

Joel T. Veit
Senior Vice President and Treasurer
717-972-1100
ir@selectmedical.com

Cision View original content:https://www.prnewswire.com/news-releases/select-medical-holdings-corporation-completes-spin-off-of-concentra-302315858.html

SOURCE Select Medical Holdings Corporation

FAQ

What is the exchange ratio for Select Medical's (SEM) Concentra spin-off?

Stockholders received 0.806971 shares of Concentra stock for every share of Select Medical stock held as of November 18, 2024.

How many Concentra shares did Select Medical (SEM) distribute in the spin-off?

Select Medical distributed 104,093,503 shares of Concentra common stock, representing approximately 81.7% of Concentra's outstanding shares.

When did Select Medical (SEM) complete the Concentra spin-off?

Select Medical completed the Concentra spin-off on November 25, 2024.

What happens to fractional shares in Select Medical's (SEM) Concentra distribution?

Stockholders will receive cash in lieu of any fractional shares of Concentra stock they would have otherwise received.

SELECT MEDICAL HOLDINGS CORP

NYSE:SEM

SEM Rankings

SEM Latest News

SEM Stock Data

2.74B
105.93M
17.32%
78.96%
1.56%
Medical Care Facilities
Services-hospitals
Link
United States of America
MECHANICSBURG